Proton Therapy in Reducing Toxicity in Anal Cancer

• Status: Active, not recruiting
• Trial end date: 2023-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research study is to determine whether the amount of radiation given to the normal areas around the anal cancer can be reduced by using Proton Therapy while reducing the side effects that are seen with standard therapy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jordan Kharofa
• Treatments: Mitomycin; Mitomycins

Criteria

Inclusion Criteria:

• Karnofsky Performance Status >70%

• Histologically documented squamous or basaloid carcinoma of the anal canal

• Stage T2-4 disease with any N category

Exclusion Criteria:

• Patients with a life expectancy of < 3 months.